Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

Xgeva, Prolia (denosumab) Linked to Low Calcium Deaths


|
Xgeva, Prolia (denosumab) Linked to Low Calcium Deaths

November 14, 2012 — In the latest issue of Best Pills, Worst Pills, the consumer advocacy group Public Citizen is warning that manufacturers of Xgeva and Prolia (denosumab) have not warned American consumers about the risk of deadly low calcium levels (hypocalcemia), despite the fact that this side effect has caused multiple deaths. Furthermore, European and Canadian health regulators have issued warnings, but the U.S. Food and Drug Administration (FDA) has not warned about the risk.

Unfortunately, some physicians and patients taking Xgeva and Prolia may not be aware about the risk of hypocalcemia (dangerously low calcium levels), which can trigger seizures, irregular heart rhythm, and death. Public Citizen recommended that patients who are taking these drugs should consult their physician about the risk of hypocalcemia.

Xgeva (120-mg of denosumab) and Prolia (60-mg of denosumab) are injection medications used to treat bone-loss. Xgeva is administered once every 4 weeks to treat patients with bone cancer. Prolia is administered once every 6 months to treat patients with osteoporosis (chronic loss of bone density associated with bone fractures).

Unfortunately, three deaths have been linked to Xgeva induced hypocalcemia. Serious injuries have also been reported with Prolia, but no deaths.

In response to the injuries and deaths, the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) published recommendations that doctors should check patients for pre-existing hypocalcemia before they prescribe Xgeva or Prolia. Furthermore, as a preventative measure, the MHRA recommended prescribing calcium and Vitamin D supplements for patients on these drugs, unless the patient has dangerously high calcium levels.

Health officials in Canada have also published a safety communication. They warned that hypocalcemia was most likely to occur in patients who were just starting the drugs, in the first 6 months of treatment. Patients with poor kidney function were also more likely to suffer from hypocalcemia.

Symptoms of hypocalcemia include:

  • Altered mental status, confusion
  • Emotional problems (anxiety, depression)
  • Seizures
  • Abnormal heart rhythm
  • Muscle spasms (tetany)
  • And more

Do I have an Xgeva Lawsuit?

The Schmidt Firm, PLLC is currently accepting Xgeva (denosumab) induced injury cases in all 50 states. If you or somebody you know has been injured by Xgeva, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Product Liability & Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation's leading plaintiff's law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firms reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.